Dark

Check out our Dark Pool Levels

ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
stock NASDAQ

Inactive

Jul 31, 2024

6.64USD-25.924%(-2.32)94,462

Pre-market

0.00USD-100.000%(-8.96)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

06:30AM EDT Business Combination of Amicus Gene Therapy Business with ARYA IV to Resultin the Launch of Caritas Therapeutics, a New Independent, Publicly Traded Companywith Expected ~$400M in Initial Funding GlobeNewswire Inc

Feb 26, 2021

09:07AM EST ARYA Sciences Acquisition Corp IV Shares Will Open For Quote At 10:35 a.m. EST, Expected To Open For Trade After 10:45 a.m. EST; IPO Priced At $10/Unit Benzinga

Feb 25, 2021

08:42PM EST ARYA Sciences Acquisition Prices IPO Of 13 Mln Class A Ordinary Shares At $10.00/shr RTTNews

Share